Literature DB >> 18308577

Imaging and dosimetry of 99mTc EC annexin V: preliminary clinical study targeting apoptosis in breast tumors.

Hiroaki Kurihara1, David J Yang, Massimo Cristofanilli, William D Erwin, Dong-Fang Yu, Saady Kohanim, Richard Mendez, E Edmund Kim.   

Abstract

BACKGROUND: Early detection of cellular events is important to predict the outcome of the patients. This study was aimed to use (99m)Tc EC-annexin V to image tumor cells undergoing apoptosis.
METHODS: In 10 patients with breast cancer, scintigraphic images and dosimetric estimates were obtained after administering (99m)Tc EC-annexin V.
RESULTS: Nine of the 10 cases showed detectable (99m)Tc EC-annexin V uptake in tumor. Higher values of T/N ratios are associated with patient after treatment.
CONCLUSIONS: Apoptosis can be quantified using (99m)Tc EC-annexin V.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18308577      PMCID: PMC2562036          DOI: 10.1016/j.apradiso.2008.01.012

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN: 0969-8043            Impact factor:   1.513


  32 in total

1.  Programmed Cell Death (Apoptosis) and Cancer Chemotherapy.

Authors: 
Journal:  Cancer Control       Date:  1996-07       Impact factor: 3.302

2.  Diagnostic utility of tumor vascularity on magnetic resonance imaging of the breast.

Authors:  Y Ando; H Fukatsu; T Ishiguchi; T Ishigaki; T Endo; M Miyazaki
Journal:  Magn Reson Imaging       Date:  2000-09       Impact factor: 2.546

3.  In vivo and in vitro measurement of apoptosis in breast cancer cells using 99mTc-EC-annexin V.

Authors:  D J Yang; A Azhdarinia; P Wu; D F Yu; W Tansey; S K Kalimi; E E Kim; D A Podoloff
Journal:  Cancer Biother Radiopharm       Date:  2001-02       Impact factor: 3.099

4.  99mTc-ethylenedicysteine-folate: a new tumor imaging agent. Synthesis, labeling and evaluation in animals.

Authors:  S Ilgan; D J Yang; T Higuchi; F Zareneyrizi; H Bayhan; D Yu; E E Kim; D A Podoloff
Journal:  Cancer Biother Radiopharm       Date:  1998-12       Impact factor: 3.099

5.  Technetium-99m HYNIC-annexin V: a potential radiopharmaceutical for the in-vivo detection of apoptosis.

Authors:  K Ohtsuki; K Akashi; Y Aoka; F G Blankenberg; S Kopiwoda; J F Tait; H W Strauss
Journal:  Eur J Nucl Med       Date:  1999-10

Review 6.  Receptor imaging: competitive or complementary to antibody imaging?

Authors:  S J Goldsmith
Journal:  Semin Nucl Med       Date:  1997-04       Impact factor: 4.446

Review 7.  Does fluorine-18 fluorodeoxyglucose metabolic imaging of tumours benefit oncology?

Authors:  C S Brock; S R Meikle; P Price
Journal:  Eur J Nucl Med       Date:  1997-06

Review 8.  Polychemotherapy for early breast cancer: an overview of the randomised clinical trials with quality-adjusted survival analysis.

Authors:  B F Cole; R D Gelber; S Gelber; A S Coates; A Goldhirsch
Journal:  Lancet       Date:  2001-07-28       Impact factor: 79.321

9.  Technetium-99m-L,L-ethylenedicysteine: a renal imaging agent. I. Labeling and evaluation in animals.

Authors:  A M Verbruggen; D L Nosco; C G Van Nerom; G M Bormans; P J Adriaens; M J De Roo
Journal:  J Nucl Med       Date:  1992-04       Impact factor: 10.057

10.  ASTRO Research Fellowship: apoptosis as a predictor of tumor response to radiation in stage IB cervical carcinoma. American Society for Therapeutic Radiology and Oncology.

Authors:  J A Wheeler; L C Stephens; C Tornos; P J Eifel; K K Ang; L Milas; P K Allen; R E Meyn
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-07-30       Impact factor: 7.038

View more
  17 in total

Review 1.  (99m)Tc-Annexin A5 quantification of apoptotic tumor response: a systematic review and meta-analysis of clinical imaging trials.

Authors:  Tarik Z Belhocine; Francis G Blankenberg; Marina S Kartachova; Larry W Stitt; Jean-Luc Vanderheyden; Frank J P Hoebers; Christophe Van de Wiele
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-08-16       Impact factor: 9.236

Review 2.  Apoptosis and apoptotic body: disease message and therapeutic target potentials.

Authors:  Xuebo Xu; Yueyang Lai; Zi-Chun Hua
Journal:  Biosci Rep       Date:  2019-01-18       Impact factor: 3.840

Review 3.  Bioresponsive nanosensors in medical imaging.

Authors:  Eyk Schellenberger
Journal:  J R Soc Interface       Date:  2009-10-21       Impact factor: 4.118

4.  Imaging apoptosis in the eye.

Authors:  M F Cordeiro; C Migdal; P Bloom; F W Fitzke; S E Moss
Journal:  Eye (Lond)       Date:  2011-03-25       Impact factor: 3.775

Review 5.  Nuclear imaging of the breast: translating achievements in instrumentation into clinical use.

Authors:  Carrie B Hruska; Michael K O'Connor
Journal:  Med Phys       Date:  2013-05       Impact factor: 4.071

6.  Single-Photon Emission Computed Tomography/Computed Tomography Imaging in a Rabbit Model of Emphysema Reveals Ongoing Apoptosis In Vivo.

Authors:  Monica P Goldklang; Yared Tekabe; Tina Zelonina; Jordis Trischler; Rui Xiao; Kyle Stearns; Alexander Romanov; Valeria Muzio; Takayuki Shiomi; Lynne L Johnson; Jeanine M D'Armiento
Journal:  Am J Respir Cell Mol Biol       Date:  2016-12       Impact factor: 6.914

7.  Clinical applications in molecular imaging.

Authors:  Carola Heneweer; Jan Grimm
Journal:  Pediatr Radiol       Date:  2010-12-03

8.  Longitudinal PET imaging of doxorubicin-induced cell death with 18F-Annexin V.

Authors:  Shuo Hu; Dale O Kiesewetter; Lei Zhu; Ning Guo; Haokao Gao; Gang Liu; Naoki Hida; Lixin Lang; Gang Niu; Xiaoyuan Chen
Journal:  Mol Imaging Biol       Date:  2012-12       Impact factor: 3.488

Review 9.  Phosphatidylserine targeting for diagnosis and treatment of human diseases.

Authors:  Kristof Schutters; Chris Reutelingsperger
Journal:  Apoptosis       Date:  2010-09       Impact factor: 4.677

10.  Approaching solid tumor heterogeneity on a cellular basis by tissue proteomics using laser capture microdissection and biological mass spectrometry.

Authors:  Donald J Johann; Jaime Rodriguez-Canales; Sumana Mukherjee; DaRue A Prieto; Jeffrey C Hanson; Michael Emmert-Buck; Josip Blonder
Journal:  J Proteome Res       Date:  2009-05       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.